<div id="content" class="col-md-12" style="">
<div data-drupal-messages-fallback="" class="hidden"/><div id="block-medsites-page-title" class="widget block">
<h1><span property="schema:name">Bone Marrow Transplant</span>
</h1>
</div>
<div id="block-medsites-content" class="widget block">
<article data-history-node-id="2986" role="article" about="/commodorecompendium/bone-marrow-transplant" typeof="schema:WebPage">
<div>
<div property="schema:text" class="field field--name-body field--type-text-with-summary field--label-hidden field__item"><div style="border-bottom:solid windowtext 1.0pt; border-top:double windowtext 1.5pt; border-left:none; border-right:none; padding:1.0pt 0in 1.0pt 0in">
<p style="border:none; padding:0in"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><b><span style="font-size:12.0pt"><span style="font-family:Palatino">Bone Marrow Transplant – Michael LaPelusa</span></span></b></span></span></span></p>
</div>
<p><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Background</span></span></span></span></span></p>
<ul>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Donor selection </span></span></span></span></span></span>
<ul style="list-style-type:circle">
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="tab-stops:9.0pt"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Autologous: self, no matching required</span></span></span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="tab-stops:9.0pt"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Allogeneic: non-self, matching based on HLA (more matching -&gt; less GVHD risk)</span></span></span></span></span></span></span>
<ul style="list-style-type:disc">
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="tab-stops:9.0pt"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Matched-related donor (MRD): fully matched sibling</span></span></span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="tab-stops:9.0pt"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Matched-unrelated donor (MUD): From NMDP database </span></span></span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="tab-stops:9.0pt"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Haploidentical: Half matched sibling or parent</span></span></span></span></span></span></span></li>
</ul>
</li>
</ul>
</li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Source of stem cells:</span></span></span></span></span></span>
<ul style="list-style-type:circle">
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="tab-stops:9.0pt"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Peripheral blood stem cells (PBSCs) vs bone marrow-derived cells vs umbilical cord</span></span></span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="tab-stops:9.0pt"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Timeline for transplant:T -14 d: cell mobilization and collection (G-CSF used to help mobilize stem cells)</span></span></span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="tab-stops:9.0pt"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">T -8 d to T-3d: conditioning regimen, initiation of GVHD ppx, TLS ppx and sinusoidal obstruction syndrome ppx</span></span></span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="tab-stops:9.0pt"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">T = 0 d: transplant</span></span></span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="tab-stops:9.0pt"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">T +7 d to T +30 d: engraftment </span></span></span></span></span></span></span></li>
</ul>
</li>
</ul>
<p> </p>
<p><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Complications/Adverse Effects:</span></span></span></span></span></p>
<ul>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Infectious</span></span></span><span style="font-size:12.0pt"><span style="font-family:Palatino">: Neutropenic fever, typhlitis, GNR, HSV, respiratory/enteral viruses (adenovirus, RSV, parainfluenza), Aspergillus, Candida</span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Non</span></span></span><span style="font-size:12.0pt"><span style="font-family:Palatino">-infectious    </span></span></span></span></span>
<ul style="list-style-type:circle">
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="tab-stops:9.0pt"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Nausea, vomiting, mucositis</span></span></span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="tab-stops:9.0pt"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Cytopenia’s: Transfuse as needed (plt &gt;10, hematocrit &gt;21)</span></span></span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="tab-stops:9.0pt"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Hepatic</span></span></span><span style="font-size:12.0pt"><span style="font-family:Palatino"> veno-occlusive disease/sinusoidal obstructive syndrome:</span></span></span></span></span></span>
<ul style="list-style-type:disc">
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="tab-stops:9.0pt"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">2/2 cytotoxic venule damage from chemo resulting in thrombi formation</span></span></span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="tab-stops:9.0pt"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Diagnosis: T Bili &gt;2, hepatomegaly/RUQ pain, weight gain &gt; 2-5%   </span></span></span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="tab-stops:9.0pt"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Evaluation: RUQ US with doppler</span></span></span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="tab-stops:9.0pt"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Treatment: Per heme attending; Consider defibrotide </span></span></span></span></span></span></span></li>
</ul>
</li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="tab-stops:9.0pt"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Graft failure – primary (persistent neutropenia without engraftment) or secondary (delayed pancytopenia 2/2 immune phenomena or infection after engraftment)</span></span></span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="tab-stops:9.0pt"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Engraftment</span></span></span><span style="font-size:12.0pt"><span style="font-family:Palatino"> syndrome:</span></span></span></span></span></span>
<ul style="list-style-type:disc">
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="tab-stops:9.0pt"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Pathophys: PMN recovery -&gt; cytokine storm -&gt; vascular leak</span></span></span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="tab-stops:9.0pt"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Symptoms: fever, tachycardia, hypotension, SOB, pulmonary edema, rash, weight gain, bone pain, confusion</span></span></span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="tab-stops:9.0pt"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Diagnosis: clinical; Workup specific symptoms</span></span></span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="tab-stops:9.0pt"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Treatment: high-dose IV steroids</span></span></span></span></span></span></span></li>
</ul>
</li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="tab-stops:9.0pt"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Acute GVHD: </span></span></span></span></span></span></span>
<ul style="list-style-type:disc">
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="tab-stops:9.0pt"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Only in allogenic; Increased risk with more HLA mismatch</span></span></span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="tab-stops:9.0pt"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Pathophys: donor T cells attack recipient (Th1-mediated)</span></span></span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="tab-stops:9.0pt"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Symptoms: skin rash, cholestatic liver injury, diarrhea</span></span></span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="tab-stops:9.0pt"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Treatment: IV steroids (methylprednisolone 1-2mg/kg x 5d) </span></span></span></span></span></span></span>
<ul style="list-style-type:circle">
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="tab-stops:9.0pt"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">If refractory: mycophenolate, etanercept, ruxolitinib, antithymocyte globulin </span></span></span></span></span></span></span></li>
</ul>
</li>
</ul>
</li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="tab-stops:9.0pt"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Chronic GVHD (typically after T+100d s/p allo)</span></span></span></span></span></span></span>
<ul style="list-style-type:disc">
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="tab-stops:9.0pt"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Can involve all organs but typically see a scleroderma-like picture (xerophthalmia, xerostomia dysphagia, arthritis, skin changes, malar rash, obliterative bronchiolitis, cholestatic liver injury, cytopenia’s)</span></span></span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="tab-stops:9.0pt"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Treatment: steroids (also photophoresis for skin), consider trials of ruxolitinib, ibrutinib, rituximab if refractory</span></span></span></span></span></span></span></li>
</ul>
</li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="tab-stops:9.0pt"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">PTLD</span></span></span></span></span></span></span></li>
</ul>
</li>
</ul>
</div>
</div>
</article>
</div>
</div>